JP Morgan Chase
DMAA icon

JP Morgan Chase’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

JP Morgan Chase’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$556K Buy
51,475
+1,584
+3% +$17K ﹤0.01% 5135
2026
Q2 		$531K Buy
49,891
+10
+0% +$106 ﹤0.01% 5054
2026
Q1 		$523K Buy
49,881
+60
+0.1% +$627 ﹤0.01% 4969
2025
Q4 		$517K Sell
49,821
-49,869
-50% -$515K ﹤0.01% 5011
2025
Q3 		$1.02M Buy
+99,690
New +$1.02M ﹤0.01% 4571

Other funds holding DMAA

Mizuho Securities USA
Mizuho Securities USA New York $6.3B AUM 30.7% 1-Year Est. Return
Karpus Investment Management
Karpus Investment Management Pittsford, New York $3.34B AUM 3.39% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
First Trust Capital Management
First Trust Capital Management Chicago, Illinois $2.08B AUM 59.2% 1-Year Est. Return
Westchester Capital Management (New York)
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 22.91% 1-Year Est. Return
Crossingbridge Advisors
Crossingbridge Advisors Pleasantville, New York $571M AUM 0.32% 1-Year Est. Return
RLH Capital
RLH Capital Great Neck, New York $277M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dakota Wealth Management
Dakota Wealth Management Palm Beach Gardens, Florida $5.38B AUM 27.63% 1-Year Est. Return
Arax Advisory Partners
Arax Advisory Partners Denver, Colorado $17.7B AUM 20.22% 1-Year Est. Return

JP Morgan Chase's DMAA Position: Q3 2026 in Review

JP Morgan Chase increased its Drugs Made In America Acquisition Corp (DMAA) stake by 3.2% in Q3 2026, buying an estimated $17K and bringing the position to 51,475 shares worth $556K. The position accounts for ﹤0.01% of the portfolio, ranked #5135.

JP Morgan Chase first reported a position in DMAA in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.02M in Q3 2025. 12 funds tracked by Wall St. Rank hold DMAA as of Q3 2026.

  • JP Morgan Chase held 51,475 shares of Drugs Made In America Acquisition Corp worth $556K as of Q3 2026.
  • JP Morgan Chase bought 1,584 Drugs Made In America Acquisition Corp shares in Q3 2026, an estimated $17K.
  • Drugs Made In America Acquisition Corp made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #5135 holding.
  • JP Morgan Chase first reported a position in Drugs Made In America Acquisition Corp in Q3 2025 and has held it in 5 quarters since.
  • JP Morgan Chase's Drugs Made In America Acquisition Corp position peaked at $1.02M in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.